Cardiovascular Risk Factors in Transgender People after Gender-Affirming Hormone Therapy.
Esteban Sánchez-ToscanoJesús Domínguez-RiscartLaura Larrán-EscandónIsabel Mateo-GaviraManuel Aguilar-DiosdadoPublished in: Journal of clinical medicine (2023)
In our setting, transgender people developed changes in their metabolic profiles in the first year after hormonal treatment. Both transmen and transwomen showed early alterations in lipid and carbohydrate metabolism, slight elevations in blood pressure, and a tendency to gain weight. This makes lifestyle interventions necessary from the beginning of GAHs.
Keyphrases
- cardiovascular risk factors
- physical activity
- blood pressure
- metabolic syndrome
- cardiovascular disease
- weight loss
- hiv testing
- body mass index
- mental health
- fatty acid
- hypertensive patients
- heart rate
- weight gain
- stem cells
- polycystic ovary syndrome
- insulin resistance
- body weight
- blood glucose
- cell therapy
- combination therapy
- glycemic control